We're still accepting applications for fall 2025!
Apply Today
Epidemiologist Abram Wagner discusses why US funding for global vaccination programs benefits Americans through job creation, disease prevention, and economic stability, while building international goodwill and protecting vulnerable populations worldwide.
The University of Michigan School of Public Health hosted keynote speaker Dr. Ashish Jha in the “Disrupting Infectious Diseases: Fighting for Our Future” seminar as part of the recently launched biannual speaker series The Exchange: Critical Conversations with Michigan Public Health.
In this Q&A, Michigan Public Health Research Specialist Blair Whittington explains the findings from the latest report from the Michigan COVID-19 Recovery Surveillance Study (MI CReSS).
In this Q&A, Michigan Public Health and Georgia Institute of Technology researchers discuss recent research discovering that cellphone coverage was associated with a significant reduction in Ebola cases during the 2014 outbreak in Liberia.
Kristi Gamarel and Sari Reisner are leading an evaluation of a program called LEAP (Legal, Economic, and Affirming Peer Support) as part of the NIH-funded Adolescent Medicine Trials Network for HIV Interventions. LEAP addresses social factors that have been linked to inequities in HIV prevention and care outcomes for trans youth of color.
US flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says University of Michigan School of Public Health researcher Arnold Monto.